Acute Kidney Injury in Upper GI Bleeding Patients
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorSohag University
About this trial
This study aims to evaluate the incidence of acute kidney injury (AKI) among patients presenting with acute upper gastrointestinal bleeding (UGIB) at Sohag University Hospitals, and to identify predictors associated with renal impairment in these patients.
Eligibility criteria
Qualifiers
Adult patients aged 18 years or older
Patients presenting with clinical features suggestive of acute upper gastrointestinal bleeding (UGIB), including hematemesis, coffee-ground vomiting, or melena
Diagnosis of UGIB confirmed by upper gastrointestinal endoscopy or strong clinical evidence when endoscopy is not immediately available
Patients admitted to Sohag University Hospitals (medical wards or intensive care unit)
Disqualifiers
Patients with end-stage renal disease (ESRD) on chronic dialysis
Patients with a history of renal transplantation
Patients with advanced chronic kidney disease stage 5 (eGFR <15 mL/min/1.73 m²) not on dialysis
Patients with lower gastrointestinal bleeding
Trial design
Treatments tested in this trial
- Observational assessment
Treatment groups
200 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov